The purpose of this study is to determine if mupirocin 2% in polyethylene glycol (PEG)
ointment [Treatment Arm] is effective in preventing moderate to severe re-infection with
Staphylococcus aureus compared with treatment with polyethylene glycol (PEG) ointment
[Placebo Arm].
Phase:
Phase 4
Details
Lead Sponsor:
US Department of Veterans Affairs VA Office of Research and Development
Collaborators:
Saint Joseph Mercy Health System University of Michigan